Full Transcript: Belite Bio Q1 2026 Earnings Call - Belite Bio (NASDAQ:BLTE)
AI disclosure
Summary
by Benzinga Insights Benzinga Staff Writer Follow Good afternoon everyone. Thank you for joining us. On the call today are Dr. Tom Lin, Chairman and CEO of Bel...